Metformin NDC 70518-4651

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-4651Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-4651Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70518-4651-0	70518465100	30 POUCH in 1 BOX (70518-4651-0) / 1 TABLET, EXTENDED RELEASE in 1 POUCH (70518-4651-1)Marketed from Apr 30, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Metformin
Generic name (nonproprietary): metformin
Active ingredients: Metformin hydrochloride — 1000 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: REMEDYREPACK INC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209674
Marketing start: Apr 30, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Biguanides (Chemical structure)
Identifiers: Product ID 70518-4651_50c0b704-0706-da22-e063-6394a90aa3c9SPL ID 50c0b704-0706-da22-e063-6394a90aa3c9SPL set ID 27f603ec-25e6-4270-a7a3-34a64a76f7efRxCUI 1807894UNII 786Z46389E
Pharmacologic class: Biguanide

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518465100 followed by a unit qualifier and the quantity

Package 70518-4651-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 1, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Metformin hydrochloride extended-release tablets are a biguanide indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) Metformin hydrochloride extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 209674

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209674
Product	Strength	Form · route	Labeler	Product NDC
Metformin	Metformin hydrochloride 500 mg/1	Tablet, Extended releaseOral	Ingenus Pharmaceuticals, LLC	50742-633
Metformin	Metformin hydrochloride 500 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-1557
Metformin	Metformin hydrochloride 1000 mg/1	Tablet, Extended releaseOral	Ingenus Pharmaceuticals, LLC	50742-634
Metformin	Metformin hydrochloride 1000 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-1584